Cargando…
Intramammary 25-hydroxyvitamin D(3) and 1,25-dihydroxyvitamin D(3) treatments differentially increase serum calcium and milk cell gene expression
Intramammary 25-hydroxyvitamin D(3) (25D) and 1,25-dihydroxyvitamin D(3) (1,25D) treatments stimulate immune defenses of the mammary gland. We hypothesized 25D treatment, in contrast to 1,25D, would exert activity in the mammary gland without affecting serum calcium. The objective was to determine t...
Autores principales: | Wells, T.L., Poindexter, M.B., Kweh, M.F., Blakely, L.P., Nelson, C.D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039239/ https://www.ncbi.nlm.nih.gov/pubmed/36974222 http://dx.doi.org/10.3168/jdsc.2022-0336 |
Ejemplares similares
-
Primary Human Osteoblasts in Response to 25-Hydroxyvitamin D(3), 1,25-Dihydroxyvitamin D(3) and 24R,25-Dihydroxyvitamin D(3)
por: van der Meijden, Karen, et al.
Publicado: (2014) -
25-Hydroxyvitamin D(3) and 1,25-Dihydroxyvitamin D(3) Promote the Differentiation of Human Subcutaneous Preadipocytes
por: Nimitphong, Hataikarn, et al.
Publicado: (2012) -
25-Hydroxyvitamin D, 1,25-Dihydroxyvitamin D, and Peripheral Bone Densitometry in Adults with Celiac Disease
por: Ciacci, Carolina, et al.
Publicado: (2020) -
Characteristics of Serum Ratios of 1,25-Dihydroxyvitamin D to 25-Hydroxyvitamin D for Assessment of Bone Metabolism
por: Yamamoto, Koichiro, et al.
Publicado: (2021) -
Treatment of an Intramammary Bacterial Infection with 25-Hydroxyvitamin D(3)
por: Lippolis, John D., et al.
Publicado: (2011)